ArticleEuropean radiology experimental2026
Geometric morphological parameters from cardiac magnetic resonance imaging in assessment of chronic pulmonary thromboembolism, a prospective pilot study.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveThe role of geometric-morphological parameters derived from cardiac magnetic resonance imaging (CMR) in assessing and stratifying chronic pulmonary thromboembolism (CPTE) remains unclear. MATERIAL AND
methodsWe prospectively enrolled 53 CPTE patients (16 with chronic thromboembolic pulmonary disease (CTEPD), 37 with chronic thromboembolic pulmonary hypertension (CTEPH)) and 53 age- and sex-matched healthy controls. All patients underwent CMR and right heart catheterization within 24 h. Biventricular fractal dimension (FD) and perimeter-area ratio (PAR) were quantified on short-axis cine images at end-diastole and end-systole across basal, mid, and apical levels. Group comparisons, ROC analysis, and Spearman correlations were performed. Incremental diagnostic value was assessed using multivariable logistic regression, net reclassification improvement, and integrated discrimination improvement.
resultsRight ventricular (RV) FD was significantly higher and RVPAR lower in CTEPH, most pronounced at the apical level, both in end-diastole and end-systole (p < 0.05). Apical RVFD and RVPAR robustly differentiated CPTE from controls (AUC = 0.911-0.961) and CTEPH from CTEPD (AUC = 0.819-0.895). Both parameters provided significant incremental diagnostic value over RVEF. In univariable analysis, RVFD correlated positively with afterload indices and negatively with perfusion/output metrics; RVPAR showed inverse associations (all p < 0.05). Multivariable linear regression showed that RVPAR retained weak independent negative associations with mean pulmonary arterial pressure and pulmonary vascular resistance.
conclusionCMR-derived apical RVFD and RVPAR reflect early, load-dependent ventricular remodeling in CPTE and demonstrated potential as complementary non-invasive imaging markers for severity assessment and risk stratification, highlighting the apex as the most sensitive site of RV adaptation. KEY POINTS: Question The role of CMR-derived fractal dimension and perimeter-area ratio in assessing right ventricular remodeling and differentiating CTEPH from CTEPD remains unclear. Findings Apical RVFD and RVPAR differentiated CPTE from controls (AUC 0.911-0.961) and CTEPH from CTEPD (AUC 0.819-0.895), correlated with PVR and mPAP, and provided incremental diagnostic value over RVEF. Relevance statement This pilot study suggests that cine-derived fractal dimension and perimeter-area ratio can characterize right ventricular remodeling, correlate with invasive hemodynamics, and provide incremental diagnostic value over conventional functional indices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.